Search
for
Sort by
Research 541–570 of 1000+
- PA15 Becker naevus syndrome associated with a mosaic pathogenic variant in <i>ACTB</i>
- Polycystic Ovaries: A Cross Sectional Study on Unmarried Girls in KSA
- A reasonable Response to Diphensiprone in Pediatric Alopecia Patient: A Case Report
- 596 Application of an artificial intelligence (AI) photographic device to track platelet-rich plasma treatment outcomes in females with alopecia
- Functionally enhanced placenta-derived mesenchymal stem cells inhibit adipogenesis in orbital fibroblasts with Graves’ ophthalmopathy
- Alopecia barbae: A natural way to cure it by the aids of moutarde d’Orléans and tumeric powder
- The childbearing years: hair diseases
- Cutaneous reactions to recombinant cytokine therapy
- Dermal Mucinosis in the Eosinophilia-Myalgia Syndrome
- Alopecia Areata in an Adolescent With Inflammatory Bowel Disease
- Lichen Planopilaris
- The Biology of Hair Follicles
- The North American Menopause Society Recommendations for Clinical Care of Midlife Women
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Frontal fibrosing alopecia: A review of 60 cases
- Frontal fibrosing alopecia: a survey in 16 patients
- Human epithelial hair follicle stem cells and their progeny: Current state of knowledge, the widening gap in translational research and future challenges
- Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management
- Primary cicatricial alopecia
- Dermatologic manifestations of endocrine disorders
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Alopecia: evaluation and treatment
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Imbalance of T‐helper 17 and regulatory T cells in patients with alopecia areata
- Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor
- The role of lymphocytes in the development and treatment of alopecia areata
- Oxidative Damage Control in a Human (Mini-) Organ: Nrf2 Activation Protects against Oxidative Stress-Induced Hair Growth Inhibition
- ACNE